Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.

Falavarjani, Khalil Ghasemi; Amirsardari, Anahita; Habibi, Abbas; Eshaghi, Acieh; Bakhti, Shohreh; Aghdam, Kaveh Abri

Falavarjani, Khalil Ghasemi; Amirsardari, Anahita; Habibi, Abbas; Eshaghi, Acieh; Bakhti, Shohreh; Aghdam, Kaveh Abri.

Affiliation

Falavarjani KG; Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Amirsardari A; Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Habibi A; Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Eshaghi A; Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Bakhti S; Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Aghdam KA; Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

J Ophthalmic Vis Res ; 12(3): 281-289, 2017.

Article de En | MEDLINE | ID: mdl-28791061

Mots clés

Central Serous Chorioretinopathy; Optical Coherence Tomography; Spironolactone; Subretinal Fluid

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Ophthalmic Vis Res Année: 2017 Type de document: Article Pays d'affiliation: Iran Pays de publication: Émirats arabes unis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google